Arteric Sponsors Digital Pharma West

Arteric, a digital healthcare marketing agency that fuses exceptional software development skill with healthcare marketing expertise to help brands connect patients, caregivers, and healthcare professionals with the health information and tools that patients need to live longer, healthier lives announced today that they will again be a major sponsor for the 2017 Digital Pharma West Conference taking place in San Francisco from June 13 to June 15.

Digital Pharma West is one of the healthcare industry’s most eagerly anticipated events. Thought leaders from pharmaceutical, biotechnology, and medical device companies meet with their counterparts from the strategic marketing and marketing technology companies that support their efforts to engage patients and healthcare providers. Representatives from academia and government healthcare offices join these groups to discuss the spectrum of opportunities and challenges that digital technology creates in the healthcare space

Jayson Mercado, head of digital events for ExL Events and lead organizer for Digital Pharma West comments. “We’re happy and lucky to partner with Arteric annually on our Digital Pharma events. Whether it’s how to integrate new technologies, improve patient and HCP communications, or strengthen broader digital strategy, they have their finger on the pulse of the topics being discussed at our conferences. As a digital agency with a deep roster of life science clients, they can weigh in on many of the issues being discussed from multiple perspectives.”

Digital Pharma West is the largest healthcare digital marketing conference on the West Coast, yet is highly regarded for its intimate environment that cultivates frequent, highly productive conversations between attendees from every aspect of pharma development and healthcare marketing. “Arteric’s mission revolves around connecting patients and healthcare providers with life-saving and life-enhancing information — which aligns perfectly with the broad collection of speakers and thought leaders who attend.” states Hans Kaspersetz, Arteric’s president and co-founder. “The opportunity to connect with a broad array of commercial pharma and biotech leaders provides invaluable insight that I can take back and integrate into our client work.”

Attendees will have much to discuss — the comprehensive agenda includes strategy and tactics that affect every stage of the pharma product life cycle and the patient journey. Topics include delivering an end-to-end digital experience for customers and end users, assessing omnichannel user experience, driving digital transformation, and content development technologies. In addition, social media strategy, tactics and technology will be discussed in a separate full-day session.

Mr. Kaspersetz continues, “The variety of topics and the ease of connecting with thought leaders working through challenges similar to those facing our clients creates a tremendous learning opportunity for our team. Meetings like this, Digital Pharma West in particular, give us a sense of what’s being talked about, and more importantly, why it’s being discussed.”

Learn more about Digital Pharma West

Arteric Technology Utilized in Hypertension Medication Adherence Study at Baylor College of Medicine

OnTimeRx® Automated Reminder Service Tested in Stroke Prevention Program Targeting African-American Women

Arteric is a digital agency, but ultimately, we’re in the life extension business. By blending exceptional software development skills with healthcare marketing expertise, we help brands and healthcare organizations connect patients, caregivers and healthcare professionals with the health information and tools they need to live longer, healthier lives.

Susan Torrico, a career pharmacist and medication-adherence pioneer, is also in the life extension business. In 2000, after watching too many patients lose their transplanted organs because they didn’t follow their anti-rejection treatment regimens, Susan began experimenting with mobile technology as a method to improve medication adherence. As Susan explains, “It was devastating seeing so many people, especially teens, miss out on an opportunity for a healthier life simply because they didn’t take their medication. At that point, I developed the concept that became OnTimeRx®.”

In 2005, Arteric teamed up with Susan to develop the OnTimeRx® Automated Reminder Service — mobile technology that provides Web-based reminder-scheduling and notification messages that are delivered by text message, phone call or email. The Automated Reminder Service is the most recent addition to the OnTimeRx® adherence software collection, which include apps for the iPhone® and iPad®, for Android smartphones, and for Windows® desktop computers. These software apps provide reminders in the form of alarm sounds and/or on-screen notices as an alternative to text messages, phone calls or email.

We’re very interested in determining if the automated phone and email reminders sent by OnTimeRx® improve medication adherence in this at-risk population. Preliminary results from a very small patient population look promising.

In addition to transplant patients, OnTimeRx® technology has been applied in adherence studies involving HIV treatment in young people. It was inspiring to learn that OnTimeRx® software is now being evaluated in a population at risk for hypertension.1 African-American women are more prone to hypertension than non-African Americans — 47.5% vs 28%.2,3 Medication non-adherence can cause these women to develop a decreased threshold for stroke development or an increased progression of cardiovascular disease.

To address this issue, researchers at the Baylor College of Medicine are implementing the OnTimeRx® Automated Reminder Service in a pilot study investigating the efficacy of smartphone-based services to improve medication adherence.4 The study is funded by The Lone Star Stroke Consortium, which is a Texas-based collaboration of major stroke centers, and the Texas Nursing Association-District 9.

Study researcher Vanessa Monroe, Clinical Assistant Professor at Prairie View A&M University College of Nursing and PhD Candidate at Texas Woman’s University-Houston, shared these thoughts with us. “We’re very interested in determining if the automated phone and email reminders sent by OnTimeRx® improve medication adherence in this at-risk population.” Vanessa continued, “Preliminary results from a very small patient population look promising. We’re in the midst of adding more patients to the study.”

We’ll keep you informed about Vanessa’s progress, because non-adherence remains a vexing challenge, with rates ranging from 30% to 60% depending on the condition, the treatment, the patient and the setting.4 Medication error rates are just as worrisome — 20% to 80% of patients make mistakes and up to 60% of patients stop their medication too soon.Non-adherence also creates an economic burden. The cost of drug-related morbidity and mortality in the ambulatory setting in the United States has been estimated to be as high as $136 billion.5

Nonadherence has many contributing factors, and so presents a moving target. But mobile communication technology is continually evolving, and we’re evolving our platforms and extending OnTimeRx® functionality to help patients and healthcare providers meet the challenge.

LEARN MORE ABOUT ONTIMERX

Software solutions  from apps to enterprise

Arteric connects patients, caregivers, and healthcare professionals to the health information they need to live longer, healthier lives. We achieve this by finding and filling unmet needs with intuitive well designed technologies. However needs change and technology evolves, count on Arteric to combine infinite curiosity, what if? thinking and unstoppable software expertise to develop life-changing custom mobile apps and out-of-the-box-ready enterprise solutions for pharma, biotech and life science marketers and the people that they help

For information about OnTimeRx® products, contact Jon Fisher at 201.546.9902.
For information about the clinical trial, contact Vanessa Monroe at 832.971.8682.

OnTimeRx is a registered trademark of Arteric.
Windows is a trademark of Microsoft Corporation                                             iPhone and iPad are trademarks of Apple Inc., registered in the U.S. and other countries.
Android is a trademark of Google Inc.

References

  1. Monroe V, Dello Stritto R, Langford R, Young A. (2017). Texas Woman’s University-Houston. Testing a Smartphone Application Intervention to Improve Medication Adherence in African American Female Clinic Patients with Unstable High Blood Pressure: A Two Group Randomized Control Trial. Presented at the Southern Nurse Research Society Symposium. Dallas, Texas.
  2. Taylor J, Peternell B, Smith J. (2013). Attitudes toward genetic testing for hypertension among African American women and girls. Nurs Res Pract. 2013;2013:341374. doi:10.1155/2013/341374 
  3. Still C, Craven T, Freedman B, et al. (2015). Baseline characteristics of African Americans in the systolic blood pressure intervention trial. J Am Soc Hypertens. 2015;9(9), 670-679. doi:10.1016/j.jash.2015.06.012
  4. Gottlieb H. Medication Nonadherence: Finding Solutions to a Costly Medical Problem. Medscape. Available at http://www.medscape.com/viewarticle/409940_6. Accessed May 3, 2017.
  5. Johnson J, Bootman J. (1995) Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med (18):1949-56.

ARTERIC APPOINTS NEW DIRECTOR OF TECHNOLOGY

Fast-growing pharmaceutical and biotechnology digital agency broadens its digital healthcare capabilities with 15-year veteran.

Summit, NJ (PR.com)- Arteric (http://arteric.com) is pleased to announce that Jon Fisher has joined the company as its new Director of Technology. Jon has worked in technology and digital marketing for 15 years and has spent the past 9 years working in a healthcare marketing agency.

Jon has played a key role in the development of digital strategy for multiple pharmaceutical companies, including Gilead, Astra Zeneca, Boehringer Ingelheim, Celgene, Alkermes, Biogen, Abbott, and others across many brands, from pre-launch to full promotional launch.

Jon is well versed in the development of Web sites, customer relationship management programs, mobile apps, e-commerce sites, and digital tactics across the board. Jon is always looking for innovative yet practical solutions to problems in the healthcare environment, while always keeping the end users in mind.

Hans Kaspersetz, co-Founder and President of Arteric, comments:

“As Arteric grows, it’s essential for our teams to have the appropriate mix of skills and experience necessary to grow our business for the long term, and Jon certainly brings that mix.”

Jon has experience across an array of therapeutic categories, including cardiology, dermatology, endocrinology, infectious disease, psychiatry, and rheumatology. He says,

“I’m excited to join the team at Arteric. Because of my wealth of experience in digital solutions for so many therapeutic categories, I can help Arteric deliver top-quality work to our clients.”

Jon is from upstate New York, has a passion for travel, and lives by the motto “try anything once.”

About Arteric

Arteric is a digital agency for pharmaceutical and biotechnology brands. Arteric has leading-edge expertise in launching new drug brands and growing corporate brands. Arteric creates inspiring strategies and technologies that improve peoples’ lives.